Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|June 27, 2019
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cellsMaria Chiara Proto, Donatella Fiore, Giovanni Forte, et al.
Pharmacological Reviews|November 23, 2011
Pharmacological actions of statins: a critical appraisal in the management of cancerPatrizia Gazzerro, Maria Chiara Proto, Giuseppina Gangemi, et al.
Cell Death and Differentiation|October 14, 2017
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic fluxRoberta Ranieri, Elena Ciaglia, Giuseppina Amodio, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cellsChiara Laezza, Alba D'Alessandro, Simona Paladino, et al.
Molecular Pharmacology|September 20, 2008
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinaseIolanda Esposito, Maria Chiara Proto, Patrizia Gazzerro, et al.
International Journal of Molecular Sciences|April 16, 2020
Multifaceted Role of PRDM Proteins in Human CancerAmelia Casamassimi, Monica Rienzo, Erika Di Zazzo, et al.
Food Chemistry|December 12, 2024
Carob (Ceratonia siliqua) leaves: A comprehensive analysis of bioactive profile and health-promoting potential of an untapped resourceSimona Serio, Valentina Santoro, Rita Celano, et al.
Endocrine-Related Cancer|March 23, 2010
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cellsChiara Laezza, Anna Maria Malfitano, Maria Chiara Proto, et al.
Cancers|October 2, 2019
N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor SuppressorDonatella Fiore, Chiara Piscopo, Maria Chiara Proto, et al.
Blood|April 5, 2011
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesisSimona Pisanti, Paola Picardi, Lucia Prota, et al.
Pageof 4